Accelerate medical writing with Generative AI

Yseop Copilot is reimagining the future of work for the largest pharmaceutical companies in the world

WHITEPAPER

YSEOP'S GENAI WHITEPAPER NOW AVAILABLE

The pharmaceutical industry is undergoing one of the most significant transformations in history with the introduction of Generative AI. Discover how the world’s largest pharmaceutical firms have accelerated drug development and significantly reduced time to market throughout the clinical trial process using AI in our new whitepaper.

Scale medical and regulatory writing requirements with automation

Save time and money

Accelerate medical review time by 200% and increase efficiency of complex processes at scale.

Empower your people

Liberate teams from tedious, repetitive tasks and get back thousands of hours of writing and review time.

Drive digital transformation

Modernize workflows and transform how your business operates to succeed in the new AI-powered world.

The leader in Generative AI for pharmaceutical companies, Yseop Copilot changes the way workflow automation solutions are delivered with a human-centric, AI platform.

Life Sciences

Offering fully configurable Automation Packs to accelerate core medical report writing needs

Automation for Life Sciences

Yseop helps bring drugs to market faster by automating the data analysis and report generation required by regulators.

Preclinical

Deliver highly accurate narratives by automating parts of the preclinical document review cycle.

Clinical

Our solution helps medical writers do more in less time by automating key clinical components of the CTD in module 2 and 5.

Quality
(Coming Soon)

Discover how automation saves lives, money, and quickens the march to market.

The future of work is augmented.

See how Yseop’s powerful medical writing AI can drastically cut time to market with full workflow automation.

Each day that a new drug or vaccine gets to market sooner, it creates $1-3 Million in accelerated revenue

It used to take us a minimum of 4 hours to write 1 patient narrative. Now, it takes 4 seconds to write an unlimited number of them.

We wanted to be certain and very accurate around what we produce in these documents that are submitted to health authorities. We want to deliver a draft through Artificial Intelligence that is 100% reliable and needs no further editing by human medical writers. That is what we have achieved with the Yseop collaboration.

Machine learning is a part of every aspect of Lilly’s future, from drug discovery to clinical trials to manufacturing to patient support. Yseop brings a novel approach to regulatory submissions and other reporting, and we see opportunities to bring Yseop’s technology to teams throughout the enterprise.

News & Press Releases

At the forefront of innovations and developments in AI and NLG.

Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation

September 5, 2024
News & Press Releases

Yseop Copilot integrates with Veeva Vault RIM for one-click document generation in medical writing.

Cognizant and Yseop announce plan to partner to scale medical writing through Generative AI

July 11, 2024
News & Press Releases

Cognizant’s AI and industry expertise, combined with Yseop’s generative AI platform, aims to improve the productivity of scientific writers across the life sciences value chain

With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma

May 1, 2024
News & Press Releases

Already a leading provider of Generative AI for life sciences, Yseop leverages AWS for greater scalability and the acceleration of new drug introductions